Share Your Events with the NMD4C
The NMD4C strives to provide opportunities for our members for continuing neuromuscular training, development of knowledge and skills, and collaborate with other neuromuscular stakeholders; If you or your organization are hosting a neuromuscular event, conference or webinar, we would like to help you share it with our neuromuscular members! Over the upcoming year, the NMD4C will showcase events from the neuromuscular community on our website and through our social media channels. For further information and to have the NMD4C share your event, please contact network communications coordinator James Davis at .
Currently, the NMD4C offers monthly webinars in partnership with MDC as a part of our “Let’s Talk NMD” series, special webinars hosted by individual network working groups, the three-part Defeat Duchenne Canadian Conference in partnership with Jesse’s Journey and MDC, and early-career networking events over the past year; all of these events both past and present, can be found on our website.
Read next...
Hope on the Horizon: Trials, Treatments and Therapies for DMD, DM1 & MG
Nov 25-28, 2025 | Join us at Hope on the Horizon to learn more about the treatment and clinical trial landscape for Duchenne Muscular Dystrophy, Myotonic Dystrophy Type 1 and Myasthenia Gravis from key experts in the field!
2026 Awards Now Open for Nominations!
We’re proud to recognize outstanding achievements across the neuromuscular research community with our Three awards: Publication of the Year, Early Career Biomedical/Clinical Researchers of the Year.
A Milestone in Neuromuscular Care: AGAMREE® (vamorolone) Approved as the First Treatment for Duchenne Muscular Dystrophy in Canada
Health Canada has approved AGAMREE® (vamorolone), the first-ever treatment for Duchenne Muscular Dystrophy (DMD) in Canada. Patient Support Program opens for enrollment on October 10, 2025.